home / stock / atnm / atnm short
Short Information | Actinium Pharmaceuticals Inc. (NYSE:ATNM)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 159,519 |
Total Actual Volume | 7,286,532 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 7,976 |
Average Short Percentage | 2.52% |
Is there a ATNM Short Squeeze or Breakout about to happen?
See the ATNM Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
01-13-2025 | $1.3 | $1.26 | $1.3 | $1.24 | 118,500 | 11,530 | 9.73% |
01-10-2025 | $1.29 | $1.28 | $1.31 | $1.25 | 216,857 | 3,731 | 1.72% |
01-08-2025 | $1.39 | $1.31 | $1.4188 | $1.31 | 166,153 | 10 | 0.01% |
01-07-2025 | $1.43 | $1.39 | $1.47 | $1.36 | 207,325 | 3,092 | 1.49% |
01-06-2025 | $1.45 | $1.43 | $1.48 | $1.3901 | 283,783 | 4,525 | 1.59% |
01-03-2025 | $1.27 | $1.44 | $1.45 | $1.27 | 388,265 | 13,265 | 3.42% |
01-02-2025 | $1.27 | $1.26 | $1.34 | $1.25 | 468,686 | 13,777 | 2.94% |
12-31-2024 | $1.19 | $1.26 | $1.28 | $1.17 | 580,470 | 5,246 | 0.9% |
12-30-2024 | $1.2 | $1.17 | $1.215 | $1.16 | 418,720 | 11,238 | 2.68% |
12-27-2024 | $1.28 | $1.2 | $1.29 | $1.175 | 477,781 | 18,074 | 3.78% |
12-26-2024 | $1.2 | $1.29 | $1.29 | $1.165 | 296,428 | 2,000 | 0.67% |
12-24-2024 | $1.24 | $1.22 | $1.24 | $1.15 | 141,941 | 4,189 | 2.95% |
12-23-2024 | $1.28 | $1.24 | $1.29 | $1.19 | 301,837 | 3,863 | 1.28% |
12-20-2024 | $1.14 | $1.29 | $1.29 | $1.125 | 1,084,004 | 1,196 | 0.11% |
12-19-2024 | $1.19 | $1.12 | $1.1992 | $1.1 | 357,424 | 9,380 | 2.62% |
12-18-2024 | $1.22 | $1.16 | $1.26 | $1.16 | 383,476 | 10,558 | 2.75% |
12-17-2024 | $1.27 | $1.22 | $1.29 | $1.22 | 294,599 | 7,733 | 2.62% |
12-16-2024 | $1.21 | $1.27 | $1.28 | $1.2 | 381,276 | 7,661 | 2.01% |
12-13-2024 | $1.23 | $1.23 | $1.23 | $1.16 | 434,089 | 23,478 | 5.41% |
12-12-2024 | $1.32 | $1.25 | $1.34 | $1.22 | 284,918 | 4,973 | 1.75% |
News, Short Squeeze, Breakout and More Instantly...
Actinium Pharmaceuticals Inc. Company Name:
ATNM Stock Symbol:
NYSE Market:
Actinium Pharmaceuticals Inc. Website:
Actinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024 PR Newswire - Aligned with FDA on operationally seamless Phase 2/3 trial for Actimab-A + CLAG-M in relapsed/refractory acute myelo...
Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors PR Newswire - Dr. Almenoff brings more than 25 years of drug development and leadership experience to the Actini...
Actinium Pharmaceuticals Announces Publication of Results from the Phase 3 SIERRA Trial of Iomab-B in the Journal of Clinical Oncology PR Newswire Iomab-B is the first CD45 targeted radiotherapy for conditioning in development to enable potentially curative bone marrow transpl...